Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.900
+0.45010.11%
Volume:45.07M
Turnover:217.97M
Market Cap:30.79B
PE:9.24
High:4.920
Open:4.680
Low:4.670
Close:4.450
52wk High:5.668
52wk Low:4.340
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:16.05
T/O Rate:0.72%
Dividend:0.14
Dividend Rate:2.87%
EPS(LYR):0.530
ROE:7.57%
ROA:2.66%
PB:0.54
PE(LYR):9.24
PS:0.10

Loading ...

BRIEF-China Resources Pharmaceutical Says Fund Established With Proposed Size Of RMB500 Mln

Reuters
·
Oct 30, 2025

CR Pharma (3320) and CR Double-Crane (600062) Announce RMB500 Million Biomedical Fund

Bulletin Express
·
Oct 30, 2025

CHINARES PHARMA (03320) Leads Establishment of RMB 500 Million Fund, Focusing on Synthetic Biology and Innovative Drugs

Stock News
·
Oct 30, 2025

China Resources Pharmaceutical Group Ltd - Commits RMB123 Mln to Fund

THOMSON REUTERS
·
Oct 30, 2025

China Resources Pharmaceutical Group - Fund Established With Proposed Size of RMB500 Mln

THOMSON REUTERS
·
Oct 30, 2025

BRIEF-China Resources Pharmaceutical Says 9M Net Profit For CR Boya Bio-Pharmaceutical At RMB343 Million

Reuters
·
Oct 27, 2025

China Resources Pharmaceutical (3320) Releases Key Financial Data of Subsidiary CR Boya Bio-pharmaceutical for the Nine Months Ended 30 September 2025

Bulletin Express
·
Oct 27, 2025

CHINARES PHARMA (03320): China Resources Boya Bio-Pharmaceutical Reports Q3 Net Profit of RMB 343 Million, Down 16.8% YoY

Stock News
·
Oct 27, 2025

China Resources Pharmaceutical - 9M Net Profit for Cr Boya Bio-Pharmaceutical RMB343 Mln

THOMSON REUTERS
·
Oct 27, 2025

China Resources Pharmaceutical Group Limited (Stock Code: 3320) Releases Key Financial Figures of Subsidiary CR Sanjiu for the First Three Quarters of 2025

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical Group Limited (3320) Announces KPC’s Unaudited Q3 2025 Results

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical (3320) Announces Jiangzhong Pharmaceutical’s Q3 2025 Financial Results

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical Group - 9 Months Revenue for Kpc Pharmaceuticals RMB4.75 Bln

THOMSON REUTERS
·
Oct 24, 2025

China Resources Pharmaceutical (3320) and Tasly Pharmaceutical Report Nine-Month 2025 Financial Results

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical (3320) Announces Dong-E-E-Jiao Q3 2025 Unaudited Financial Highlights

Bulletin Express
·
Oct 24, 2025

BRIEF-China Resources Pharmaceutical Reports 9M Revenue For Jiangzhong Pharmaceutical RMB 2.93 Billion

Reuters
·
Oct 24, 2025

China Resources Pharmaceutical (3320.HK) Announces CR Double-Crane Q3 2025 Financial Results

Bulletin Express
·
Oct 24, 2025

China Resources Pharmaceutical - 9M Net Profit for Jiangzhong Pharmaceutical RMB742.7 Mln

THOMSON REUTERS
·
Oct 24, 2025

CHINARES PHARMA (03320): Dong-E-E-Jiao Co., Ltd. Reports Net Profit of 1.277 Billion Yuan for First Three Quarters, Up 10.77% Year-on-Year

Stock News
·
Oct 24, 2025

China Resources Pharmaceutical - 9M Net Profit for China Resources Double-Crane Pharmaceutical RMB1.39 Bln

THOMSON REUTERS
·
Oct 24, 2025